Any imbalance of adiponectin from optimal serum levels might have detrimental effects, as indicated across various SARDs, including elevated levels in rheumatoid arthritis (RA) and SLE, and decreased levels in systemic sclerosis (SSc) [32]. The gene discussed is ADIPOQ; the disease is systemic sclerosis.